GPCR Excellence Beacon Discovery brings deep GPCR drug discovery expertise and a proven track record of delivering candidates into development, making it a compelling partner for GPCR focused programs in biotech and pharma.

Collaborative Track Record With past partnerships involving Janssen and Escient Pharmaceuticals, Beacon demonstrates a reliable collaboration model that can be scaled through new co development opportunities.

Eurofins Synergy As part of the Eurofins network, Beacon can access a broad client base and CDMO ecosystem, enabling more efficient introductions and potential cross selling of GPCR discovery capabilities.

Unique Discovery Library Beacon's proprietary chemistry and screening know-how enable exploration of hard to drug GPCR targets, offering a unique asset set for partners seeking novel chemistries and high value screening.

Lean Partnerships A lean, specialized team allows Beacon to operate as a flexible, cost effective partner that can accelerate discovery programs and integrate quickly into partner workflows.